(Q35117571)

English

Antisense therapy directed to protein kinase C-alpha (affinitak, LY900003/ISIS 3521): Potential role in breast cancer

scientific article published on April 1, 2003

Statements

Antisense therapy directed to protein kinase C-alpha (Affinitak, LY900003/ISIS 3521): potential role in breast cancer (English)
Antisense therapy directed to protein kinase C-alpha (affinitak, LY900003/ISIS 3521): Potential role in breast cancer (English)
2 Suppl 3

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit